Pralnacasan T16570
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Pralnacasan inhibits proinflammatory cytokines IL-18, IL-1_ , and IFN-_. Pralnacasan is an effective, non-peptide, and orally active interleukin-1_ converting enzyme inhibitor (Ki: 1.4 nM). Pralnacasan has the potential for osteoarthritis and rheumatoid a
CAS nr:
192755-52-5
Purity:
98%
Molecular Weight:
523,54
SMILES:
O=C([C@@H]1CCCN2N1C([C@@H](NC(C3=NC=CC4=C3C=CC=C4)=O)CCC2=O)=O)N[C@@H](C5)[C@H](OCC)OC5=O
Formula:
C26H29N5O7
Pathway:
Others
Target:
Others
